Global Longlife Hospital and Research Board of Directors

Get the latest insights into the leadership at Global Longlife Hospital and Research. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Dhruv Jani Managing Director
Ms. Hetal Thakkar Executive Director & CFO
Mrs. Sucheta Jani Non Executive Director
Mr. Manasvi Thapar Independent Director
Mr. Sandeep Shah Independent Director

Global Longlife Hospital and Research Share price

GLHRL

25.09

1.31 (-4.96%)
Last updated on 3 Sep, 2025 | 09:32 IST
BUYSELL
Today's High

25.09

Today's Low

25.09

52 Week Low

18.30

52 Week High

46.44

The current prices are delayed, login to your account for live prices

Global Longlife Hospital and Research FAQs

The board at Global Longlife Hospital and Research consists of experienced professionals, including Mr. Dhruv Jani , Ms. Hetal Thakkar , and others, overseeing the company’s strategic and corporate governance.

Directors at Global Longlife Hospital and Research are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Dhruv Jani is the current chairman at Global Longlife Hospital and Research.

Executive directors at Global Longlife Hospital and Research are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Global Longlife Hospital and Research adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Global Longlife Hospital and Research, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.